NO126377B - - Google Patents
Download PDFInfo
- Publication number
- NO126377B NO126377B NO00157873A NO15787365A NO126377B NO 126377 B NO126377 B NO 126377B NO 00157873 A NO00157873 A NO 00157873A NO 15787365 A NO15787365 A NO 15787365A NO 126377 B NO126377 B NO 126377B
- Authority
- NO
- Norway
- Prior art keywords
- cross
- inclusion
- cyclodextrin
- reaction
- water
- Prior art date
Links
- 229920000858 Cyclodextrin Polymers 0.000 claims description 26
- 229920005989 resin Polymers 0.000 claims description 25
- 239000011347 resin Substances 0.000 claims description 25
- 150000001875 compounds Chemical class 0.000 claims description 24
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 claims description 22
- 238000006243 chemical reaction Methods 0.000 claims description 14
- 239000003431 cross linking reagent Substances 0.000 claims description 12
- HFHDHCJBZVLPGP-UHFFFAOYSA-N schardinger α-dextrin Chemical compound O1C(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(O)C2O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC2C(O)C(O)C1OC2CO HFHDHCJBZVLPGP-UHFFFAOYSA-N 0.000 claims description 11
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims description 10
- 238000000034 method Methods 0.000 claims description 8
- 230000001588 bifunctional effect Effects 0.000 claims description 7
- BRLQWZUYTZBJKN-UHFFFAOYSA-N Epichlorohydrin Chemical compound ClCC1CO1 BRLQWZUYTZBJKN-UHFFFAOYSA-N 0.000 claims description 3
- 230000002378 acidificating effect Effects 0.000 claims description 2
- 239000003463 adsorbent Substances 0.000 claims description 2
- 239000003223 protective agent Substances 0.000 claims description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 14
- 239000000203 mixture Substances 0.000 description 13
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 11
- 229940097362 cyclodextrins Drugs 0.000 description 11
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 9
- 239000000126 substance Substances 0.000 description 9
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 8
- 239000000243 solution Substances 0.000 description 6
- 239000000843 powder Substances 0.000 description 5
- 150000001720 carbohydrates Chemical class 0.000 description 4
- 235000014633 carbohydrates Nutrition 0.000 description 4
- 238000004132 cross linking Methods 0.000 description 4
- 239000000376 reactant Substances 0.000 description 4
- 239000002904 solvent Substances 0.000 description 4
- 238000001179 sorption measurement Methods 0.000 description 4
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 239000000725 suspension Substances 0.000 description 3
- DEWLEGDTCGBNGU-UHFFFAOYSA-N 1,3-dichloropropan-2-ol Chemical compound ClCC(O)CCl DEWLEGDTCGBNGU-UHFFFAOYSA-N 0.000 description 2
- LSTZTHCEEPHCNQ-UHFFFAOYSA-N 3-(2,5-dioxabicyclo[2.1.0]pentan-3-yloxy)-2,5-dioxabicyclo[2.1.0]pentane Chemical compound C1(C2C(O2)O1)OC1C2C(O2)O1 LSTZTHCEEPHCNQ-UHFFFAOYSA-N 0.000 description 2
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 2
- 239000004593 Epoxy Substances 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 2
- 238000004587 chromatography analysis Methods 0.000 description 2
- 150000002118 epoxides Chemical group 0.000 description 2
- 238000002955 isolation Methods 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- FSBYOEHUNSUUTD-UHFFFAOYSA-N 2-(2,5-dioxabicyclo[2.1.0]pentan-3-yloxy)ethanol Chemical compound C1(C2C(O2)O1)OCCO FSBYOEHUNSUUTD-UHFFFAOYSA-N 0.000 description 1
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 1
- 239000004971 Cross linker Substances 0.000 description 1
- ZFIVKAOQEXOYFY-UHFFFAOYSA-N Diepoxybutane Chemical compound C1OC1C1OC1 ZFIVKAOQEXOYFY-UHFFFAOYSA-N 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 239000001569 carbon dioxide Substances 0.000 description 1
- 229910002092 carbon dioxide Inorganic materials 0.000 description 1
- 125000001309 chloro group Chemical group Cl* 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 238000010908 decantation Methods 0.000 description 1
- 238000004821 distillation Methods 0.000 description 1
- -1 e.g. vitamins Chemical class 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 239000000839 emulsion Substances 0.000 description 1
- 230000002255 enzymatic effect Effects 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 239000008098 formaldehyde solution Substances 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 125000005843 halogen group Chemical group 0.000 description 1
- 239000011261 inert gas Substances 0.000 description 1
- WSFSSNUMVMOOMR-NJFSPNSNSA-N methanone Chemical compound O=[14CH2] WSFSSNUMVMOOMR-NJFSPNSNSA-N 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- JCXJVPUVTGWSNB-UHFFFAOYSA-N nitrogen dioxide Inorganic materials O=[N]=O JCXJVPUVTGWSNB-UHFFFAOYSA-N 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 230000001590 oxidative effect Effects 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000011541 reaction mixture Substances 0.000 description 1
- 230000035484 reaction time Effects 0.000 description 1
- 230000000717 retained effect Effects 0.000 description 1
- 150000003384 small molecules Chemical class 0.000 description 1
- 230000000087 stabilizing effect Effects 0.000 description 1
- 239000007858 starting material Substances 0.000 description 1
- 229920003002 synthetic resin Polymers 0.000 description 1
- 239000000057 synthetic resin Substances 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
- C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
- C08B37/0006—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid
- C08B37/0009—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid alpha-D-Glucans, e.g. polydextrose, alternan, glycogen; (alpha-1,4)(alpha-1,6)-D-Glucans; (alpha-1,3)(alpha-1,4)-D-Glucans, e.g. isolichenan or nigeran; (alpha-1,4)-D-Glucans; (alpha-1,3)-D-Glucans, e.g. pseudonigeran; Derivatives thereof
- C08B37/0012—Cyclodextrin [CD], e.g. cycle with 6 units (alpha), with 7 units (beta) and with 8 units (gamma), large-ring cyclodextrin or cycloamylose with 9 units or more; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L27/00—Spices; Flavouring agents or condiments; Artificial sweetening agents; Table salts; Dietetic salt substitutes; Preparation or treatment thereof
- A23L27/70—Fixation, conservation, or encapsulation of flavouring agents
- A23L27/72—Encapsulation
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L27/00—Spices; Flavouring agents or condiments; Artificial sweetening agents; Table salts; Dietetic salt substitutes; Preparation or treatment thereof
- A23L27/70—Fixation, conservation, or encapsulation of flavouring agents
- A23L27/74—Fixation, conservation, or encapsulation of flavouring agents with a synthetic polymer matrix or excipient, e.g. vinylic, acrylic polymers
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L27/00—Spices; Flavouring agents or condiments; Artificial sweetening agents; Table salts; Dietetic salt substitutes; Preparation or treatment thereof
- A23L27/70—Fixation, conservation, or encapsulation of flavouring agents
- A23L27/75—Fixation, conservation, or encapsulation of flavouring agents the flavouring agents being bound to a host by chemical, electrical or like forces, e.g. use of precursors
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J20/00—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof
- B01J20/22—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof comprising organic material
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C201/00—Preparation of esters of nitric or nitrous acid or of compounds containing nitro or nitroso groups bound to a carbon skeleton
- C07C201/06—Preparation of nitro compounds
- C07C201/16—Separation; Purification; Stabilisation; Use of additives
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
- C08B31/00—Preparation of derivatives of starch
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
- C08L5/00—Compositions of polysaccharides or of their derivatives not provided for in groups C08L1/00 or C08L3/00
- C08L5/16—Cyclodextrin; Derivatives thereof
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Polymers & Plastics (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nutrition Science (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Materials Engineering (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- General Health & Medical Sciences (AREA)
- Analytical Chemistry (AREA)
- Investigating Or Analyzing Non-Biological Materials By The Use Of Chemical Means (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
- Solid-Sorbent Or Filter-Aiding Compositions (AREA)
- Treatment Of Liquids With Adsorbents In General (AREA)
- Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CH561564A CH445129A (fr) | 1964-04-29 | 1964-04-29 | Procédé pour la préparation de composés d'inclusion à poids moléculaire élevé |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NO126377B true NO126377B (enExample) | 1973-01-29 |
Family
ID=4296563
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO00157873A NO126377B (enExample) | 1964-04-29 | 1965-04-28 | |
| NO00170961A NO127814B (enExample) | 1964-04-29 | 1967-12-13 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO00170961A NO127814B (enExample) | 1964-04-29 | 1967-12-13 |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US3420788A (enExample) |
| BE (1) | BE662174A (enExample) |
| CH (1) | CH445129A (enExample) |
| DK (1) | DK132259C (enExample) |
| ES (1) | ES312034A1 (enExample) |
| GB (1) | GB1091637A (enExample) |
| IT (1) | IT961352B (enExample) |
| NL (1) | NL6505361A (enExample) |
| NO (2) | NO126377B (enExample) |
| SE (2) | SE333240B (enExample) |
Families Citing this family (113)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| HU177419B (en) * | 1978-07-13 | 1981-10-28 | Chinoin Gyogyszer Es Vegyeszet | Process for preparing threedimensional,retentive polymers consisting of cyclodextrin and polyvinylalcohol units,capable of forming inclusion complexes in the form of bead,fibre or mainly block |
| EP0013688B1 (en) * | 1978-12-15 | 1984-02-01 | Kyoshin Co., Ltd. | A perfumed synthetic resin product and a method of producing said product |
| JPS609524B2 (ja) * | 1979-06-01 | 1985-03-11 | 理化学研究所 | シクロデキストリンの回収法 |
| HU184066B (en) * | 1979-12-28 | 1984-06-28 | Chinoin Gyogyszer Es Vegyeszet | Plant growth regulating substance and process for preparing such compound |
| HU181733B (en) * | 1980-08-07 | 1983-11-28 | Chinoin Gyogyszer Es Vegyeszet | Process for preparing sorbents containing cyclodextrin on cellulose base |
| JPS57130914A (en) * | 1981-02-04 | 1982-08-13 | Agency Of Ind Science & Technol | Prolongation of activity retention |
| HU189534B (en) * | 1981-09-09 | 1986-07-28 | Chinoin Rt.,Hu | Process for producing new tablets containing cyclodextrin polymer as desintegrator |
| US4448789A (en) * | 1982-08-27 | 1984-05-15 | Warner-Lambert Company | Enhanced flavor-releasing agent |
| HU191101B (en) * | 1983-02-14 | 1987-01-28 | Chinoin Gyogyszer Es Vegyeszeti Termekek Gyara Rt,Hu | Process for preparing water-soluble cyclodextrin polymers substituted with ionic groups |
| JPS6081166A (ja) * | 1983-10-11 | 1985-05-09 | Fujisawa Pharmaceut Co Ltd | 2−ニトロオキシメチル−6−クロロピリジンのβ−シクロデキストリン包接化合物およびその製造法 |
| JPS60202115A (ja) * | 1984-03-27 | 1985-10-12 | Ichiro Shibauchi | エポキシ樹脂用硬化剤 |
| US4727064A (en) * | 1984-04-25 | 1988-02-23 | The United States Of America As Represented By The Department Of Health And Human Services | Pharmaceutical preparations containing cyclodextrin derivatives |
| US4596795A (en) * | 1984-04-25 | 1986-06-24 | The United States Of America As Represented By The Secretary, Dept. Of Health & Human Services | Administration of sex hormones in the form of hydrophilic cyclodextrin derivatives |
| JPS61152765A (ja) * | 1984-12-27 | 1986-07-11 | Nippon Ekishiyou Kk | シクロデキストリン類で包接された化合物を含有した合成樹脂製品及びその製造方法 |
| US4769474A (en) * | 1985-04-10 | 1988-09-06 | Mitsui Toatsu Chemicals, Inc. | Process for purifying tryptophane |
| SE452469B (sv) * | 1986-06-18 | 1987-11-30 | Pharmacia Ab | Material bestaende av en tverbunden karboxylgrupphaltig polysackarid och forfarande vid framstellning av detsamma |
| US4897472A (en) * | 1986-11-19 | 1990-01-30 | Oy Alko Ab | Process for isolation and purification of cyclodextrins |
| US4808232A (en) * | 1986-12-08 | 1989-02-28 | American Maize-Products Company | Separation and purification of cyclodextrins |
| US5273820A (en) * | 1986-12-08 | 1993-12-28 | American Maize-Products Company | Separation and purification of cyclodextrins |
| US4898921A (en) * | 1987-06-03 | 1990-02-06 | Montclair State College | Conducting polymer films, method of manufacture and applications therefor |
| US5658894A (en) * | 1989-04-23 | 1997-08-19 | The Trustees Of The University Of Pennsylvania | Compositions for inhibiting restenosis |
| US5637575A (en) * | 1988-01-19 | 1997-06-10 | The Trustees Of The University Of Pennsylvania | Methods of inhibiting restenosis |
| US5760015A (en) * | 1988-01-19 | 1998-06-02 | The Trustees Of The University Of Pennsylvania | Cyclodextrin compounds and methods of making and use thereof |
| JPH0269540A (ja) * | 1988-09-05 | 1990-03-08 | Chisso Corp | 結晶性ポリオレフイン組成物 |
| US5441944A (en) * | 1989-04-23 | 1995-08-15 | The Trustees Of The University Of Pennsylvania | Substituted cyclodextrin sulfates and their uses as growth modulating agents |
| US5075432A (en) * | 1989-08-11 | 1991-12-24 | Edward Vanzo | Spherical cyclodextrin polymer beads |
| IT1255981B (it) * | 1991-04-30 | 1995-11-17 | Ministero Dell Uni E Della | Composizione adesiva a piu' componenti |
| US5446030A (en) * | 1991-09-19 | 1995-08-29 | Weisz; Paul B. | Prevention of hemolysis |
| AU6553994A (en) * | 1993-03-31 | 1994-10-24 | Trustees Of The University Of Pennsylvania, The | Methods of affecting the growth of living tissue in mammals and compounds and compositions therefor |
| US5492947A (en) * | 1994-06-23 | 1996-02-20 | Aspen Research Corporation | Barrier material comprising a thermoplastic and a compatible cyclodextrin derivative |
| US6048736A (en) * | 1998-04-29 | 2000-04-11 | Kosak; Kenneth M. | Cyclodextrin polymers for carrying and releasing drugs |
| WO2004064816A1 (en) * | 2003-01-16 | 2004-08-05 | Cornell Research Foundation, Inc. | PARTIALLY BIODEGRADABLE TEMPERATURE AND pH SENSITIVE HYDROGEL |
| EP2336317B1 (en) | 2003-06-13 | 2019-09-11 | Alnylam Europe AG | Double-stranded ribonucleic acid with increased effectiveness in an organism |
| PT1691811E (pt) | 2003-12-11 | 2014-10-30 | Sunovion Pharmaceuticals Inc | Combinação de um sedativo e de um modulador de neurotransmissores e métodos para melhorar a qualidade do sono e tratamento da depressão |
| US7632485B2 (en) | 2004-02-24 | 2009-12-15 | Massachusetts General Hospital | Catalytic radiofluorination |
| EP3034510A1 (en) | 2004-04-30 | 2016-06-22 | Alnylam Pharmaceuticals Inc. | Oligonucleotides comprising a c5-modified pyrimidine |
| EP1768966B1 (en) | 2004-06-17 | 2012-03-07 | Infinity Discovery, Inc. | Coumpounds and methods for inhibiting the interaction of bcl proteins with binding partners |
| MX2007010144A (es) * | 2005-02-18 | 2008-02-15 | Surface Logix Inc | Compuestos mejorados farmacocineticamente. |
| SG174829A1 (en) * | 2005-02-18 | 2011-10-28 | Surface Logix Inc | Methods of making pharmacokinetically improved compounds comprising functional residues or groups and pharmaceutical compositions comprising said compounds |
| ES2310948B2 (es) * | 2005-02-25 | 2009-09-16 | Universidade De Santiago De Compostela | Procedimiento de obtencion de hidrogeles de ciclodextrinas con glicidileteres, las composiciones obtenidas y sus aplicaciones. |
| US8669236B2 (en) * | 2005-05-12 | 2014-03-11 | The General Hospital Corporation | Biotinylated compositions |
| KR100791978B1 (ko) * | 2005-06-21 | 2008-01-04 | 곽해수 | 콜레스테롤 제거용 베타-싸이클로덱스트린의 가교화 및그의 재생방법 |
| MX2009001279A (es) | 2006-08-03 | 2009-02-11 | Tufts College | Analogos de niacina no eritematosos, y metodos para utilizar los mismos. |
| KR100785913B1 (ko) * | 2006-11-29 | 2007-12-17 | 한국과학기술연구원 | 경화된 β-사이클로덱스트린 중합체 분말과 그의 제조방법 |
| WO2009013770A1 (en) * | 2007-07-26 | 2009-01-29 | Humanitas Mirasole S.P.A. | Derivatised polysaccharide material for the transdermal administration of drugs |
| WO2009032199A1 (en) * | 2007-08-31 | 2009-03-12 | The Board Of Trustees Operating | Beta-cyclodextrins as nucleating agents for poly(lactic acid) |
| DK3133160T3 (en) | 2008-10-24 | 2019-04-01 | Sarepta Therapeutics Inc | EXON SKIP COMPOSITIONS FOR DMD |
| KR101944119B1 (ko) | 2009-11-13 | 2019-01-30 | 사렙타 쎄러퓨틱스 인코퍼레이티드 | 안티센스 항바이러스 화합물 및 인플루엔자 바이러스 감염을 치료하는 방법 |
| US9068185B2 (en) | 2010-03-12 | 2015-06-30 | Sarepta Therapeutics, Inc. | Antisense modulation of nuclear hormone receptors |
| EP2569431B1 (en) | 2010-05-13 | 2015-09-23 | Sarepta Therapeutics, Inc. | Methods for identifying compounds which modulate interleukins 17 and 23 signaling activity |
| JP5925771B2 (ja) | 2010-06-24 | 2016-05-25 | トラスティーズ オブ タフツ カレッジ | ナイアシン模倣体、およびその使用方法 |
| WO2011163612A1 (en) | 2010-06-24 | 2011-12-29 | Trustees Of Tufts College | Niacin mimetics, and methods of use thereof |
| WO2012100142A2 (en) | 2011-01-20 | 2012-07-26 | Cornell University | Treatments for retinal disorders |
| AU2012284259A1 (en) | 2011-07-15 | 2014-03-06 | Sarepta Therapeutics, Inc. | Methods and compositions for manipulating translation of protein isoforms from alternative initiation start sites |
| HRP20181022T1 (hr) | 2011-12-08 | 2018-08-24 | Sarepta Therapeutics, Inc. | Analozi oligonukleotida koji ciljaju ljudski lmna |
| AU2012355619A1 (en) | 2011-12-23 | 2014-07-17 | Novartis Ag | Compounds for inhibiting the interaction of BCL2 with binding partners |
| JP2015503515A (ja) | 2011-12-23 | 2015-02-02 | ノバルティス アーゲー | Bcl2と結合相手の相互作用を阻害するための化合物および組成物 |
| EA201491260A1 (ru) | 2011-12-23 | 2014-11-28 | Новартис Аг | Соединения и композиции для ингибирования взаимодействия bcl2 с партнерами по связыванию |
| BR112014015322A8 (pt) | 2011-12-23 | 2017-06-13 | Novartis Ag | compostos e composições para inibir a interação de bcl2 com parceiros de ligação |
| EA201491259A1 (ru) | 2011-12-23 | 2014-11-28 | Новартис Аг | Соединения и композиции для ингибирования взаимодействия bcl2 с партнерами связывания |
| DK2861579T5 (da) | 2012-05-15 | 2022-10-24 | Novartis Ag | Benzamidderivater til at hæmme aktiviteten af ABL1, ABL2 og BCR-ABL1 |
| KR20150020169A (ko) | 2012-05-15 | 2015-02-25 | 노파르티스 아게 | Abl1, abl2 및 bcr-abl1의 활성을 억제하기 위한 벤즈아미드 유도체 |
| CN104302634B (zh) | 2012-05-15 | 2017-02-08 | 诺华股份有限公司 | 用于抑制abl1、abl2和bcr‑abl1的活性的苯甲酰胺衍生物 |
| PT2900637T (pt) | 2012-05-15 | 2017-11-15 | Novartis Ag | Derivados de amida de pirimidina, piridina e pirazina substituídos com tiazole ou imidazole e compostos relacionados como inibidores de abl1, abl2 e bcr-abl1 para tratamento do cancro, infecções virais específicas e disturbios do snc específicos |
| JP6431480B2 (ja) | 2012-08-31 | 2018-11-28 | ザ ジェネラル ホスピタル コーポレイション | アルツハイマー病の治療および診断のためのビオチン複合体 |
| FR3000080B1 (fr) | 2012-12-20 | 2015-01-30 | Oreal | Polycondensat de cyclodextrine insoluble dans l'eau ; utilisations comme agent de capture |
| FR2999916B1 (fr) | 2012-12-20 | 2015-01-30 | Oreal | Composition permettant la liberation d'agent benefique comprenant un polycondensat de cyclodextrine insoluble dans l'eau et au moins un agent benefique |
| EP3885439A1 (en) | 2012-12-20 | 2021-09-29 | Sarepta Therapeutics, Inc. | Improved exon skipping compositions for treating muscular dystrophy |
| RS57106B1 (sr) | 2013-02-19 | 2018-06-29 | Novartis Ag | Derivati benzotiofena i njihove kompozicije kao selektivni degraderi estrogenskog receptora |
| KR20220061280A (ko) | 2013-03-14 | 2022-05-12 | 사렙타 쎄러퓨틱스 인코퍼레이티드 | 근육 이영양증의 치료를 위한 엑손 스키핑 조성물 |
| EP3633035A1 (en) | 2013-03-14 | 2020-04-08 | Sarepta Therapeutics, Inc. | Exon skipping compositions for treating muscular dystrophy |
| BR112015022998A2 (pt) | 2013-03-15 | 2017-11-14 | Sarepta Therapeutics Inc | composições melhoradas para o tratamento de distrofia muscular |
| US9227969B2 (en) | 2013-08-14 | 2016-01-05 | Novartis Ag | Compounds and compositions as inhibitors of MEK |
| WO2015022663A1 (en) | 2013-08-14 | 2015-02-19 | Novartis Ag | Compounds and compositions as inhibitors of mek |
| WO2015022664A1 (en) | 2013-08-14 | 2015-02-19 | Novartis Ag | Compounds and compositions as inhibitors of mek |
| WO2015092634A1 (en) | 2013-12-16 | 2015-06-25 | Novartis Ag | 1,2,3,4-tetrahydroisoquinoline compounds and compositions as selective estrogen receptor antagonists and degraders |
| CN105899491B (zh) | 2014-01-17 | 2019-04-02 | 诺华股份有限公司 | 用于抑制shp2活性的1-哒嗪-/三嗪-3-基-哌(-嗪)/啶/吡咯烷衍生物及其组合物 |
| JO3517B1 (ar) | 2014-01-17 | 2020-07-05 | Novartis Ag | ان-ازاسبيرو الكان حلقي كبديل مركبات اريل-ان مغايرة وتركيبات لتثبيط نشاط shp2 |
| WO2015107494A1 (en) | 2014-01-17 | 2015-07-23 | Novartis Ag | 1 -(triazin-3-yi_/pyridazin-3-yl)-piper(-azine)idine derivatives and compositions thereof for inhibiting the activity of shp2 |
| MX2017011103A (es) | 2015-04-01 | 2018-05-07 | Int Dioxcide Inc | Composición estabilizada para el control de olor y la deshidratación potenciada combinados. |
| WO2016203406A1 (en) | 2015-06-19 | 2016-12-22 | Novartis Ag | Compounds and compositions for inhibiting the activity of shp2 |
| EP3310779B1 (en) | 2015-06-19 | 2019-05-08 | Novartis AG | Compounds and compositions for inhibiting the activity of shp2 |
| EP3310771B1 (en) | 2015-06-19 | 2020-07-22 | Novartis AG | Compounds and compositions for inhibiting the activity of shp2 |
| EA201890811A1 (ru) | 2015-09-30 | 2018-09-28 | Сарепта Терапьютикс, Инк. | Способы лечения мышечной дистрофии |
| EA201892467A1 (ru) | 2016-04-29 | 2019-05-31 | Сарепта Терапьютикс, Инк. | Олигонуклеотидные аналоги, нацеленные на lmna человека |
| KR102457146B1 (ko) | 2016-06-14 | 2022-10-19 | 노파르티스 아게 | Shp2의 활성을 억제하기 위한 화합물 및 조성물 |
| TW201811807A (zh) | 2016-06-30 | 2018-04-01 | 美商薩羅塔治療公司 | 用於肌肉萎縮症之外顯子跳躍寡聚物 |
| KR102552428B1 (ko) | 2016-12-19 | 2023-07-06 | 사렙타 쎄러퓨틱스 인코퍼레이티드 | 근육 이상증에 대한 엑손 스킵핑 올리고머 결합체 |
| SMT202200440T1 (it) | 2016-12-19 | 2023-01-13 | Sarepta Therapeutics Inc | Coniugati di oligomeri per salto di esone per distrofia muscolare |
| EP3554552B1 (en) | 2016-12-19 | 2022-08-17 | Sarepta Therapeutics, Inc. | Exon skipping oligomer conjugates for muscular dystrophy |
| JP7679175B2 (ja) | 2017-04-20 | 2025-05-19 | エータイアー ファーマ, インコーポレイテッド | 肺の炎症を治療するための組成物および方法 |
| EA201991450A1 (ru) | 2017-09-22 | 2019-12-30 | Сарепта Терапьютикс, Инк. | Конъюгаты олигомеров для пропуска экзона при мышечной дистрофии |
| EP3687577A1 (en) | 2017-09-28 | 2020-08-05 | Sarepta Therapeutics, Inc. | Combination therapies for treating muscular dystrophy |
| US20200248178A1 (en) | 2017-09-28 | 2020-08-06 | Sarepta Therapeutics, Inc. | Combination therapies for treating muscular dystrophy |
| EP3687519A1 (en) | 2017-09-28 | 2020-08-05 | Sarepta Therapeutics, Inc. | Combination therapies for treating muscular dystrophy |
| US10758629B2 (en) | 2018-05-29 | 2020-09-01 | Sarepta Therapeutics, Inc. | Exon skipping oligomer conjugates for muscular dystrophy |
| EP3806868A4 (en) | 2018-06-13 | 2022-06-22 | Sarepta Therapeutics, Inc. | EXON SKIPPING OLIGOMERS FOR MUSCULAR DYSTROPHY |
| CN108435148A (zh) * | 2018-06-21 | 2018-08-24 | 黄益良 | 一种环糊精改性聚丙烯酰胺污水处理剂及其制备方法 |
| TW202449155A (zh) | 2018-07-27 | 2024-12-16 | 美商薩羅塔治療公司 | 用於肌肉萎縮症之外顯子跳躍寡聚物 |
| CA3122281A1 (en) | 2018-12-13 | 2020-06-18 | Sarepta Therapeutics, Inc. | Exon skipping oligomer conjugates for muscular dystrophy |
| AU2020204925B2 (en) | 2019-01-03 | 2025-11-20 | Cyclarity Therapeutics, Inc. | Cyclodextrin dimers, compositions thereof, and uses thereof |
| CN109663578B (zh) * | 2019-02-22 | 2022-02-25 | 安徽大学 | 一种对刚果红超高吸附能力的混合卤化物(MV)[BiI3Cl2]的制备方法及其产品 |
| CN109806849A (zh) * | 2019-03-25 | 2019-05-28 | 东华大学 | 一种环糊精纳米空心小球及其制备方法 |
| JP2022526763A (ja) | 2019-03-28 | 2022-05-26 | サレプタ セラピューティクス, インコーポレイテッド | カシメルセンによる筋ジストロフィーの治療方法 |
| JP2022528725A (ja) | 2019-04-18 | 2022-06-15 | サレプタ セラピューティクス, インコーポレイテッド | 筋ジストロフィーを治療するための組成物 |
| WO2020257489A1 (en) | 2019-06-19 | 2020-12-24 | Sarepta Therapeutics, Inc. | Methods for treating muscular dystrophy |
| WO2021101606A1 (en) * | 2019-11-18 | 2021-05-27 | Pmidg, Llc | Compositions for sunscreen compounds and methods thereof |
| CN113019344A (zh) * | 2021-03-16 | 2021-06-25 | 大连理工大学 | 一种具有选择性吸附的球形零价铁-环糊精复合材料的制备方法及应用 |
| CN113372674B (zh) * | 2021-08-13 | 2021-10-19 | 山东三义集团股份有限公司 | 一种氯化聚乙烯用高速挤出加工改性助剂的制备方法 |
| CN119013401A (zh) | 2022-03-17 | 2024-11-22 | 萨勒普塔医疗公司 | 二氨基磷酸酯吗啉代寡聚物缀合物 |
| WO2024073570A1 (en) | 2022-09-28 | 2024-04-04 | Altos Labs, Inc. | Expression of regeneration factors in aged/senescent cells |
| WO2024145608A2 (en) | 2022-12-30 | 2024-07-04 | Cornell University | Acid cyclodextrins for the treatment of lipofuscin buildups and ocular diseases |
| CN120441878B (zh) * | 2025-07-09 | 2025-10-17 | 成都飞机工业(集团)有限责任公司 | 一种去除无氰电镀镉溶液中金属杂质的聚合物树脂及其制备方法与使用方法 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2801184A (en) * | 1952-01-18 | 1957-07-30 | Miyamoto Katsuhei | Colloidal suspension of amylose and alpha-amylodextrin |
| NL98574C (enExample) * | 1958-01-29 | |||
| US2977356A (en) * | 1958-05-27 | 1961-03-28 | Anheuser Busch | Process for preparing cross-linked starch ethers in granule form |
| US2973243A (en) * | 1958-08-26 | 1961-02-28 | Kudera Dieter | Process for producing threads, foils, tubes and the like from amylose and/or starch carbohydrates containing amylose |
| NL252506A (enExample) * | 1959-06-12 | |||
| US2989521A (en) * | 1959-06-30 | 1961-06-20 | Frederic R Senti | Method of cross-linking and oxidizing starch |
| US3282870A (en) * | 1963-11-29 | 1966-11-01 | Dow Chemical Co | Starch and polycarboxamide reaction products |
-
1964
- 1964-04-29 CH CH561564A patent/CH445129A/fr unknown
-
1965
- 1965-04-06 IT IT7649/65A patent/IT961352B/it active
- 1965-04-07 BE BE662174D patent/BE662174A/fr unknown
- 1965-04-20 ES ES0312034A patent/ES312034A1/es not_active Expired
- 1965-04-20 US US449619A patent/US3420788A/en not_active Expired - Lifetime
- 1965-04-20 GB GB16550/65A patent/GB1091637A/en not_active Expired
- 1965-04-27 NL NL6505361A patent/NL6505361A/xx unknown
- 1965-04-28 SE SE5582/65A patent/SE333240B/xx unknown
- 1965-04-28 NO NO00157873A patent/NO126377B/no unknown
- 1965-04-28 SE SE12182/69A patent/SE365234B/xx unknown
- 1965-04-28 DK DK215765A patent/DK132259C/da active
-
1967
- 1967-12-13 NO NO00170961A patent/NO127814B/no unknown
Also Published As
| Publication number | Publication date |
|---|---|
| DK132259B (da) | 1975-11-17 |
| SE333240B (sv) | 1971-03-08 |
| DE1493047A1 (de) | 1969-01-02 |
| ES312034A1 (es) | 1966-02-01 |
| BE662174A (enExample) | 1965-10-07 |
| DK132259C (da) | 1976-05-03 |
| NL6505361A (enExample) | 1965-11-01 |
| IT961352B (it) | 1973-12-10 |
| CH445129A (fr) | 1967-10-15 |
| GB1091637A (en) | 1967-11-22 |
| SE365234B (enExample) | 1974-03-18 |
| US3420788A (en) | 1969-01-07 |
| DE1493047B2 (de) | 1973-01-11 |
| NO127814B (enExample) | 1973-08-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO126377B (enExample) | ||
| US4175183A (en) | Hydroxyalkylated cross-linked regenerated cellulose and method of preparation thereof | |
| EP0047064B1 (en) | Process for preparing porous, spherical cellulose particles | |
| NO170961B (no) | Kjemikaliebeholder og tilfoerselsanordning for fastgjoeringav denne | |
| US4872987A (en) | Process for separating and producing chlorogenic acid | |
| US4902788A (en) | Crosslinked cyclodextrins supported on porous refractory inorganic oxides | |
| JPS6317904A (ja) | 多孔質架橋ポリビニルアルコ−ル粒子の製造法 | |
| US4920214A (en) | Process for producing modified cyclodextrins | |
| US4312980A (en) | Process for preparing porous cellulose spherical particles | |
| US4547572A (en) | Cyclodextrin polymers swelling quickly and to a great extent in water and process for the preparation thereof | |
| US5075432A (en) | Spherical cyclodextrin polymer beads | |
| JPS6039558A (ja) | 分離材料およびその製造方法 | |
| CN105504295A (zh) | 一种淀粉固载β-环糊精吸附剂的制备方法 | |
| CA2577822C (en) | Method of preparing a chromatography matrix | |
| US4174440A (en) | Ionic pullulan gels and production thereof | |
| JPH0556761B2 (enExample) | ||
| JPH07216002A (ja) | シクロデキストリン誘導体の製法及びシクロデキストリン誘導体 | |
| JPH0446961B2 (enExample) | ||
| JP2896589B2 (ja) | 光学異性体分離剤 | |
| JPS6011961B2 (ja) | ポリシクロデキストリンビ−ズの製法 | |
| US3208999A (en) | Preparation of non-inhibited starch amines | |
| JPH04106101A (ja) | シクロデキストリンポリマーおよびその製造方法 | |
| US3731816A (en) | Substituted cellulose in grain form and a method of producing the same | |
| JPS6312099B2 (enExample) | ||
| JPH0222093B2 (enExample) |